Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neurosac Forte
- Development stage
- Unknown
- Lead developer
- AMSAC
- Administration
- Oral
01
Overview
Neurosac Forte is a commercial nutraceutical supplement developed by Amsac Pharma to support cognitive and neurological wellness. Formulated as an oral syrup, it contains a combination of L-carnosine, docosahexaenoic acid (DHA), and vitamin D3 (cholecalciferol). L-carnosine is a dipeptide with antioxidant and neuroprotective properties, DHA is an essential omega-3 fatty acid crucial for brain structure and function, and vitamin D3 supports overall neurological health and immune function. Neurosac Forte is marketed as a health supplement to promote cognitive development and neurological wellness as part of a balanced diet.
- Brand names
- Neurosac Forte
- Other names
- L-Carnosine, DHA & Vitamin D3 Syrup
Beyond the preview
Go deeper on Neurosac Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neurosac Forte.